These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 29790306)
1. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma. Agnihotri NS; Astekar M J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306 [TBL] [Abstract][Full Text] [Related]
2. Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma. Sasahira T; Ueda N; Yamamoto K; Kurihara M; Matsushima S; Bhawal UK; Kirita T; Kuniyasu H PLoS One; 2014; 9(3):e92534. PubMed ID: 24647631 [TBL] [Abstract][Full Text] [Related]
3. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells. Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer. Chutipongpisit K; Parachuru VP; Friedlander LT; Hussaini HM; Rich AM Int J Exp Pathol; 2021 Dec; 102(6):268-278. PubMed ID: 34791715 [TBL] [Abstract][Full Text] [Related]
5. Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination. Rudzińska M; Mikula M; Arczewska KD; Gajda E; Sabalińska S; Stępień T; Ostrowski J; Czarnocka B Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717665 [TBL] [Abstract][Full Text] [Related]
6. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis. Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228 [TBL] [Abstract][Full Text] [Related]
7. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma. Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262 [TBL] [Abstract][Full Text] [Related]
8. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells. Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087 [TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492 [TBL] [Abstract][Full Text] [Related]
10. Prediction of occult lymph node metastasis in squamous cell carcinoma of the oral cavity and the oropharynx using peritumoral Prospero homeobox protein 1 lymphatic nuclear quantification. Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y Head Neck; 2016 Sep; 38(9):1407-15. PubMed ID: 27043718 [TBL] [Abstract][Full Text] [Related]
11. Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis. Harada K; Yamazaki T; Iwata C; Yoshimatsu Y; Sase H; Mishima K; Morishita Y; Hirashima M; Oike Y; Suda T; Miura N; Watabe T; Miyazono K J Cell Sci; 2009 Nov; 122(Pt 21):3923-30. PubMed ID: 19825936 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymphatic vessel density in oral squamous cell carcinoma. Chen J; Zhang F; Hua M; Song X; Liu S; Dong Z Life Sci; 2021 Jan; 265():118746. PubMed ID: 33181177 [TBL] [Abstract][Full Text] [Related]
13. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma. Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281 [TBL] [Abstract][Full Text] [Related]
14. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation. Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789 [TBL] [Abstract][Full Text] [Related]
15. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Flister MJ; Wilber A; Hall KL; Iwata C; Miyazono K; Nisato RE; Pepper MS; Zawieja DC; Ran S Blood; 2010 Jan; 115(2):418-29. PubMed ID: 19901262 [TBL] [Abstract][Full Text] [Related]
16. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Miyahara M; Tanuma J; Sugihara K; Semba I Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352 [TBL] [Abstract][Full Text] [Related]
17. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas. Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287 [TBL] [Abstract][Full Text] [Related]
18. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression. Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362 [TBL] [Abstract][Full Text] [Related]
19. Expression of angiopoietin-2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma. Li C; Fan J; Song X; Zhang B; Chen Y; Li C; Mi K; Ma H; Song Y; Tao X; Li G PLoS One; 2013; 8(9):e75388. PubMed ID: 24040410 [TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]